IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)

NIH RePORTER · NIH · N01 · $9,211,989 · view on reporter.nih.gov ↗

Abstract

The goal of this program is to establish an integrated multi-disciplinary team of highly collaborative investigators that will plan and conduct iterative, in-depth immunologic analyses of tissue-specific and systemic responses in small animals, non-human primates (NHPs), and humans to identify the key immune responses needed for protection against Mtb; identify immunologic targets that can be used to improve TB vaccine strategies. Other research activities under the program may include determining the impact of HIV/SIV and Nontuberculous Mycobacteria (NTM) infection(s) on relevant immune responses to Mtb infection or TB vaccines and identifying how bacterial immune evasion mechanisms subvert immune responses to Mtb.

Key facts

NIH application ID
10691837
Project number
75N93019C00070-P00011-9999-1
Recipient
SEATTLE CHILDREN'S HOSPITAL
Principal Investigator
KEVIN URDAHL
Activity code
N01
Funding institute
NIH
Fiscal year
2022
Award amount
$9,211,989
Award type
Project period
2019-09-30 → 2026-09-29